1. Home
  2. MDGL vs ZWS Comparison

MDGL vs ZWS Comparison

Compare MDGL & ZWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • ZWS
  • Stock Information
  • Founded
  • MDGL 2011
  • ZWS 1891
  • Country
  • MDGL United States
  • ZWS United States
  • Employees
  • MDGL N/A
  • ZWS N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • ZWS Industrial Machinery/Components
  • Sector
  • MDGL Health Care
  • ZWS Industrials
  • Exchange
  • MDGL Nasdaq
  • ZWS Nasdaq
  • Market Cap
  • MDGL 7.5B
  • ZWS 6.1B
  • IPO Year
  • MDGL N/A
  • ZWS 2012
  • Fundamental
  • Price
  • MDGL $323.98
  • ZWS $33.17
  • Analyst Decision
  • MDGL Buy
  • ZWS Buy
  • Analyst Count
  • MDGL 10
  • ZWS 5
  • Target Price
  • MDGL $354.75
  • ZWS $38.40
  • AVG Volume (30 Days)
  • MDGL 317.3K
  • ZWS 927.0K
  • Earning Date
  • MDGL 05-06-2025
  • ZWS 04-22-2025
  • Dividend Yield
  • MDGL N/A
  • ZWS 1.09%
  • EPS Growth
  • MDGL N/A
  • ZWS 43.81
  • EPS
  • MDGL N/A
  • ZWS 0.92
  • Revenue
  • MDGL $180,133,000.00
  • ZWS $1,566,500,000.00
  • Revenue This Year
  • MDGL $228.41
  • ZWS $4.37
  • Revenue Next Year
  • MDGL $73.44
  • ZWS $5.14
  • P/E Ratio
  • MDGL N/A
  • ZWS $36.24
  • Revenue Growth
  • MDGL N/A
  • ZWS 2.35
  • 52 Week Low
  • MDGL $189.00
  • ZWS $28.25
  • 52 Week High
  • MDGL $377.46
  • ZWS $41.15
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 45.41
  • ZWS 40.43
  • Support Level
  • MDGL $310.00
  • ZWS $32.06
  • Resistance Level
  • MDGL $350.50
  • ZWS $34.49
  • Average True Range (ATR)
  • MDGL 13.02
  • ZWS 0.66
  • MACD
  • MDGL -1.72
  • ZWS 0.07
  • Stochastic Oscillator
  • MDGL 34.52
  • ZWS 45.68

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About ZWS Zurn Elkay Water Solutions Corporation

Zurn Elkay Water Solutions Corp designs procure, manufactures, and markets a range of clean water solutions for drinking water, hygiene, and sustainable water management. The Zurn Elkay product portfolio includes professional-grade water control and safety, water distribution and drainage, drinking water, finish plumbing, hygienic, environmental and site works products for public and private spaces.

Share on Social Networks: